This presentation was provided by Leslie McIntosh of Ripeta, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
This presentation was provided by Alberto Pepe of Authorea, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
This presentation was provided by Kathryn Funk of the National Library of Medicine, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
This presentation was provided by Bruce Rosenblum of Atypon, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...jodischneider
Presentation to the INRIA WIMMICS research group 2014-10-17 about our LISC paper: Using the micropublication ontology and the Open Annotation Data Model to represent evidence within a drug-drug interaction knowledge base:
http://jodischneider.com/pubs/lisc2014.pdf
http://wimmics.inria.fr/seminars
On the Reproducibility of Science: Unique Identification of Research Resourc...Nicole Vasilevsky
Poster presentation at the Data Information Literacy Symposium at Purdue University in Indiana, Sept. 2013. This study is published here: https://peerj.com/articles/148/
Linking assertions to evidence with the MicroPublications ontology WG evidenc...jodischneider
How can we link assertions to evidence in the scientific literature?
Discussion about the MicroPublications ontology (http://purl.org/mp/ & see http://arxiv.org/abs/1305.3506 )
Presented to the WG Evidence Panel of the Addressing PDDI Evidence Gaps project https://sites.google.com/site/ddikrandir/home/wg-evidence-panel
This presentation was provided by Alberto Pepe of Authorea, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
This presentation was provided by Kathryn Funk of the National Library of Medicine, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
This presentation was provided by Bruce Rosenblum of Atypon, during the NISO hot topic event "Preprints." The virtual conference was held on April 21, 2021.
Wimmics seminar--drug interaction knowledge base, micropublication, open anno...jodischneider
Presentation to the INRIA WIMMICS research group 2014-10-17 about our LISC paper: Using the micropublication ontology and the Open Annotation Data Model to represent evidence within a drug-drug interaction knowledge base:
http://jodischneider.com/pubs/lisc2014.pdf
http://wimmics.inria.fr/seminars
On the Reproducibility of Science: Unique Identification of Research Resourc...Nicole Vasilevsky
Poster presentation at the Data Information Literacy Symposium at Purdue University in Indiana, Sept. 2013. This study is published here: https://peerj.com/articles/148/
Linking assertions to evidence with the MicroPublications ontology WG evidenc...jodischneider
How can we link assertions to evidence in the scientific literature?
Discussion about the MicroPublications ontology (http://purl.org/mp/ & see http://arxiv.org/abs/1305.3506 )
Presented to the WG Evidence Panel of the Addressing PDDI Evidence Gaps project https://sites.google.com/site/ddikrandir/home/wg-evidence-panel
Recomendations for infrastructure and incentives for open science, presented to the Research Data Alliance 6th Plenary. Presenter: William Gunn, Director of Scholarly Communications for Mendeley.
Using ADAGE for pathway-style analysesCasey Greene
This talk was given at the Simons Institute Network Biology workshop. A video of the talk is available online:
https://www.youtube.com/watch?v=HpXDoMi4YO8
Data Visualization in Biomedical Sciences: More than Meets the EyeNils Gehlenborg
In science, data visualization serves two primary purposes. The first is to explore data sets interactively and the second is to communicate discoveries. However, the requirements for visualizations employed in these activities are very different. Therefore, the software tools used for these purposes are typically disconnected, creating significant challenges for reproducibility and effective communication of discoveries in data-driven biomedical science. In this presentation, I will address how a new approach to creating data visualization tools can connect data analysts and other stakeholders inside and outside the scientific community. I will introduce and demonstrate the "Vistories" approach that was motivated by these question.
Presented at the 5th Cancer Research UK Big Data Analytics Conference on Data Visualization.
OMICS Publishing Group, Journal of Nanomedicine & Biotherapeutic Discovery (JNBD) is an international, peer-reviewed journal. Each issue of Journal of Nanomedicine & Biotherapeutic Discovery presents basic, clinical, and engineering research in the field of nanomedicine and the related biotherapeutic discovery. The regular features addresses the commercialization of nanomedicine advances, ethics in nanomedicine, funding opportunities, and other topics of interest to researchers and clinicians.
Dear Editor: I read your publication ethics issue on “bogus impact factors” with great interest (1). I would like to initiate a new trend in manipulating the citation counts. There are several ethical approaches to increase the number of citations for a published paper (2). However, it is apparent that some manipulation of the number of citations is occurring (3, 4). Self - citations, “those in which the authors cite their own works” account for a significant portion of all citations (5). With the advent of information technology, it is easy to identify unusual trends for citations in a paper or a journal. A web application to calculate the single publication h - index based on (6) is available online (7, 8). A tool developed by Francisco Couto (9) can measure authors’ citation impact by excluding the self - citations. Self - citation is ethical when it is a necessity. Nevertheless, there is a threshold for self - citations. Thomson Reuters’ resource, known as the Web of Science (WoS) and currently lists journal impact factors, considers self - citation to be acceptable up to a rate of 20%; anything over that is considered suspect (10). In some journals, even 5% is considered to be a high rate of self - citations. The ‘Journal Citation Report’ is a reliable source for checking the acceptable level of self - citation in any field of study. The Public Policy Group of the London School of Economics (LSE) published a handbook for “Maximizing the Impacts of Your Research” and described self - citation rates across different groups of disciplines, indicating that they vary up to 40% (11). Unfortunately, there is no significant penalty for the most frequent self - citers, and the effect of self - citation remains positive even for very high rates of self - citation (5). However, WoS has dropped some journals from its database because of untrue trends in the citations (4). The same policy also should be applied for the most frequent self - citers. The ethics of publications should be adhered to by those who wish to conduct research and publish their findings.
No Boundary Thinking in Bioinformatics Workshop KeynoteCasey Greene
"The bounty of the commons"
In this talk, we explore how public data can become more valuable with reuse. This reuse helps us get to the bottom of cases where we are certain and wrong and helps us ask better questions.
Disease Network is the science that has emerged to diagnose a disease from a network aspect
specifically. Networks are the group that interconnect to each others similarly disease networks are
the one that reveal concelled connection among apparently independent biomedical entities like
physiologic process, signaling receptors, in addition to genetic code, also they prove to exists
intitutive in addition to powerful way to learn/discover or diagnose a disease.Due to these networks,
we can now consume the elderly drugs and its method to learn/discover the new drug
accordingly.Example- Colchicine is used in gout but after repurposing it is also used in mediterranean
fever. This is because there are many factors that affect the body during mediterranean fever and
gout, we know that gout is a form of arthritis that causes pain in joints also mediterranean fever is the
one which is accompanied by pain in joints, therefore colchicine is used as a repurposed drug again.In
repurposing of medicines or drugs we first analyse the change in symptoms and identify the target
organ and accorgingly we produce a drug that is compatible with pharmacokinetics of the body. As
the availablity of transcriptomic,proteomic and metabolomic data sources are increasing day by day it helps in classification of disease .Also there are some networks reffered to as complex networks which can be called as collection of linked junctions/ nodes
This is a presentation given at the Opal Events meeting ""Drug Discovery Partnerships: Filling the Pipeline". I was speaking in a session with Jean-Claude Bradley regarding "Pre-competitive Collaboration: Sharing Data to Increase Predictability". This presentation discussed some of the work we are doing on Open PHACTS. My thanks especially to Carole Goble, Lee Harland and Sean Ekins for their comments.
Publishers are caretakers of science. Part of that work is maintaining the integrity of scientific literature. Science builds directly upon past work, so we need to be sure that we are building upon a solid foundation and not faulty research. Publishers need to take an active role in monitoring and tracking faulty, retracted research and its influence. I'm asking publishers to (1) clearly mark retracted papers; (2) alert authors who have already cited a retracted paper; and (3) before publishing an article, check its bibliography for retracted papers.
Retracted papers should be clearly marked everywhere they appear, but today that is not the case. Publishers can also use the CrossRef CrossMark service, which lets readers check for article updates (such as retraction) from a little red ribbon at the top of an article. Checking for citations to retracted articles, and limiting future citations, can help science self-correct by shoring up its foundations.
Literature Evaluation You did a great job on your PICOT and .docxmanningchassidy
Literature Evaluation
You did a great job on your PICOT and completing this assignment. I look forward to reading your papers regarding hospital acquired infections!! You just need to work on proper formatting of your references.
Thank you,
June
Summary of Clinical Issue
The clinical issue, in this case, is patient infections. Hospitals have always been a place of refuge for patients but there is a worrying fact about infections in hospitals. Some of the patients are taken to the hospital to get better but they leave with more infections than they came in with. The issue of infections in hospitals is motivated by two major factors. The first factor is associated with medical errors. Most of the infections which occur in hospitals affect people who have gone through surgeries are people who are receiving blood, water, and food through tubes. It, therefore, means that in most cases, doctors are responsible for infections. When the inner body organs are exposed to the environment, they get exposed to germs and germs increase the chances of infections. The second factor that supports infections is hygiene in the hospital. A hospital is a sensitive place and therefore, there is a dire need to make sure that it is hygienically fit for patients. Dirt has the ability to increase high exposure to infections. Contaminated foods and drinks increase the chances of infections. It is essential to note that the cleanliness of the water and other equipment that is used in hospitals is imperative.
PICOT Question:
In hospital infections, can improved hospital hygiene reduces the number of hospital infections among patients of all ages in the next twelve months
?
Criteria
Article 1
Article 2
Article 3
APA-Formatted Article Citation with Permalink
Saint, S. (2017). Can intersectional innovations reduce hospital infection?. Journal of Hospital Infection, 95(2), 129-134. https://doi.org/10.1016/j.jhin.2016.11.013
Starr, J. B., Tirschwell, D. L., & Becker, K. J. (2017). Labetalol use is associated with increased in-hospital infection compared with nicardipine use in intracerebral hemorrhage. Stroke, 48(10), 2693-2698.
https://doi.org/10.1161/STROKEAHA.117.017230
Van Kleef, E., Luangasanatip, N., Bonten, M. J., & Cooper, B. S. (2017). Why sensitive bacteria are resistant to hospital infection control. Wellcome open research, 2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721567/
How Does the Article Relate to the PICOT Question?
The article focuses on the PICOT question.
The article focuses on the PICOT question.
The article focuses on the PICOT question.
Quantitative, Qualitative (How do you know?)
It is qualitative research because it has employed a qualitative design.
It is quantitative research because it has employed a quantitative design.
It is quantitative research because it has employed a quantitative design.
Purpose Statement
To know the role that innovations play in reducing infections in hospitals
The purpose of the article is to know the fac.
Recomendations for infrastructure and incentives for open science, presented to the Research Data Alliance 6th Plenary. Presenter: William Gunn, Director of Scholarly Communications for Mendeley.
Using ADAGE for pathway-style analysesCasey Greene
This talk was given at the Simons Institute Network Biology workshop. A video of the talk is available online:
https://www.youtube.com/watch?v=HpXDoMi4YO8
Data Visualization in Biomedical Sciences: More than Meets the EyeNils Gehlenborg
In science, data visualization serves two primary purposes. The first is to explore data sets interactively and the second is to communicate discoveries. However, the requirements for visualizations employed in these activities are very different. Therefore, the software tools used for these purposes are typically disconnected, creating significant challenges for reproducibility and effective communication of discoveries in data-driven biomedical science. In this presentation, I will address how a new approach to creating data visualization tools can connect data analysts and other stakeholders inside and outside the scientific community. I will introduce and demonstrate the "Vistories" approach that was motivated by these question.
Presented at the 5th Cancer Research UK Big Data Analytics Conference on Data Visualization.
OMICS Publishing Group, Journal of Nanomedicine & Biotherapeutic Discovery (JNBD) is an international, peer-reviewed journal. Each issue of Journal of Nanomedicine & Biotherapeutic Discovery presents basic, clinical, and engineering research in the field of nanomedicine and the related biotherapeutic discovery. The regular features addresses the commercialization of nanomedicine advances, ethics in nanomedicine, funding opportunities, and other topics of interest to researchers and clinicians.
Dear Editor: I read your publication ethics issue on “bogus impact factors” with great interest (1). I would like to initiate a new trend in manipulating the citation counts. There are several ethical approaches to increase the number of citations for a published paper (2). However, it is apparent that some manipulation of the number of citations is occurring (3, 4). Self - citations, “those in which the authors cite their own works” account for a significant portion of all citations (5). With the advent of information technology, it is easy to identify unusual trends for citations in a paper or a journal. A web application to calculate the single publication h - index based on (6) is available online (7, 8). A tool developed by Francisco Couto (9) can measure authors’ citation impact by excluding the self - citations. Self - citation is ethical when it is a necessity. Nevertheless, there is a threshold for self - citations. Thomson Reuters’ resource, known as the Web of Science (WoS) and currently lists journal impact factors, considers self - citation to be acceptable up to a rate of 20%; anything over that is considered suspect (10). In some journals, even 5% is considered to be a high rate of self - citations. The ‘Journal Citation Report’ is a reliable source for checking the acceptable level of self - citation in any field of study. The Public Policy Group of the London School of Economics (LSE) published a handbook for “Maximizing the Impacts of Your Research” and described self - citation rates across different groups of disciplines, indicating that they vary up to 40% (11). Unfortunately, there is no significant penalty for the most frequent self - citers, and the effect of self - citation remains positive even for very high rates of self - citation (5). However, WoS has dropped some journals from its database because of untrue trends in the citations (4). The same policy also should be applied for the most frequent self - citers. The ethics of publications should be adhered to by those who wish to conduct research and publish their findings.
No Boundary Thinking in Bioinformatics Workshop KeynoteCasey Greene
"The bounty of the commons"
In this talk, we explore how public data can become more valuable with reuse. This reuse helps us get to the bottom of cases where we are certain and wrong and helps us ask better questions.
Disease Network is the science that has emerged to diagnose a disease from a network aspect
specifically. Networks are the group that interconnect to each others similarly disease networks are
the one that reveal concelled connection among apparently independent biomedical entities like
physiologic process, signaling receptors, in addition to genetic code, also they prove to exists
intitutive in addition to powerful way to learn/discover or diagnose a disease.Due to these networks,
we can now consume the elderly drugs and its method to learn/discover the new drug
accordingly.Example- Colchicine is used in gout but after repurposing it is also used in mediterranean
fever. This is because there are many factors that affect the body during mediterranean fever and
gout, we know that gout is a form of arthritis that causes pain in joints also mediterranean fever is the
one which is accompanied by pain in joints, therefore colchicine is used as a repurposed drug again.In
repurposing of medicines or drugs we first analyse the change in symptoms and identify the target
organ and accorgingly we produce a drug that is compatible with pharmacokinetics of the body. As
the availablity of transcriptomic,proteomic and metabolomic data sources are increasing day by day it helps in classification of disease .Also there are some networks reffered to as complex networks which can be called as collection of linked junctions/ nodes
This is a presentation given at the Opal Events meeting ""Drug Discovery Partnerships: Filling the Pipeline". I was speaking in a session with Jean-Claude Bradley regarding "Pre-competitive Collaboration: Sharing Data to Increase Predictability". This presentation discussed some of the work we are doing on Open PHACTS. My thanks especially to Carole Goble, Lee Harland and Sean Ekins for their comments.
Publishers are caretakers of science. Part of that work is maintaining the integrity of scientific literature. Science builds directly upon past work, so we need to be sure that we are building upon a solid foundation and not faulty research. Publishers need to take an active role in monitoring and tracking faulty, retracted research and its influence. I'm asking publishers to (1) clearly mark retracted papers; (2) alert authors who have already cited a retracted paper; and (3) before publishing an article, check its bibliography for retracted papers.
Retracted papers should be clearly marked everywhere they appear, but today that is not the case. Publishers can also use the CrossRef CrossMark service, which lets readers check for article updates (such as retraction) from a little red ribbon at the top of an article. Checking for citations to retracted articles, and limiting future citations, can help science self-correct by shoring up its foundations.
Literature Evaluation You did a great job on your PICOT and .docxmanningchassidy
Literature Evaluation
You did a great job on your PICOT and completing this assignment. I look forward to reading your papers regarding hospital acquired infections!! You just need to work on proper formatting of your references.
Thank you,
June
Summary of Clinical Issue
The clinical issue, in this case, is patient infections. Hospitals have always been a place of refuge for patients but there is a worrying fact about infections in hospitals. Some of the patients are taken to the hospital to get better but they leave with more infections than they came in with. The issue of infections in hospitals is motivated by two major factors. The first factor is associated with medical errors. Most of the infections which occur in hospitals affect people who have gone through surgeries are people who are receiving blood, water, and food through tubes. It, therefore, means that in most cases, doctors are responsible for infections. When the inner body organs are exposed to the environment, they get exposed to germs and germs increase the chances of infections. The second factor that supports infections is hygiene in the hospital. A hospital is a sensitive place and therefore, there is a dire need to make sure that it is hygienically fit for patients. Dirt has the ability to increase high exposure to infections. Contaminated foods and drinks increase the chances of infections. It is essential to note that the cleanliness of the water and other equipment that is used in hospitals is imperative.
PICOT Question:
In hospital infections, can improved hospital hygiene reduces the number of hospital infections among patients of all ages in the next twelve months
?
Criteria
Article 1
Article 2
Article 3
APA-Formatted Article Citation with Permalink
Saint, S. (2017). Can intersectional innovations reduce hospital infection?. Journal of Hospital Infection, 95(2), 129-134. https://doi.org/10.1016/j.jhin.2016.11.013
Starr, J. B., Tirschwell, D. L., & Becker, K. J. (2017). Labetalol use is associated with increased in-hospital infection compared with nicardipine use in intracerebral hemorrhage. Stroke, 48(10), 2693-2698.
https://doi.org/10.1161/STROKEAHA.117.017230
Van Kleef, E., Luangasanatip, N., Bonten, M. J., & Cooper, B. S. (2017). Why sensitive bacteria are resistant to hospital infection control. Wellcome open research, 2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721567/
How Does the Article Relate to the PICOT Question?
The article focuses on the PICOT question.
The article focuses on the PICOT question.
The article focuses on the PICOT question.
Quantitative, Qualitative (How do you know?)
It is qualitative research because it has employed a qualitative design.
It is quantitative research because it has employed a quantitative design.
It is quantitative research because it has employed a quantitative design.
Purpose Statement
To know the role that innovations play in reducing infections in hospitals
The purpose of the article is to know the fac.
Ontology-Driven Clinical Intelligence: A Path from the Biobank to Cross-Disea...Remedy Informatics
The discovery of clinical insights through effective management and reuse of data requires several conditions to be optimized: Data need to be digital, data need to be structured, and data need to be standardized in terms of metadata and ontology. This presentation describes a bioinformatics system that combines a next-generation biobank management model mapped to applicable international standards and guidelines with a master ontology that controls all input and output and is able to add unique properties to meet the specialized needs of clinicians for cross-disease research.
Leveraging Publicly Accessible Clinical Trails Data Sharing, Dissemination an...Vaticle
In the broader realm of the advancement of science and the betterment of the human condition, there are several purported benefits for sharing clinical trials and research data. The scientific community has just begun to embrace open-access datasets to build their knowledge base, gain insight into new discoveries, and generate novel data-driven hypotheses that were not initially formulated in the studies. With the increasing amount of clinical trial data available, comes the need to leverage a multitude of shared datasets. Your knowledge base needs to facilitate discovery across research domains.
This talk highlights the data sharing, dissemination, and repurposing of clinical and molecular studies generated by government-funded research consortia. Further, we are building a new knowledge base resource, IMMGRAKN to facilitate translational discovery from crowd-sourced clinical trials data in ImmPort (www.immport.org), an NIH-NIAID funded open-access immunology database and analysis portal. The case studies demonstrating the use of IMMGRAKN will be discussed
Thesis Proposal, as presented for dissertation proposal defenseHeather Piwowar
The slides I presented for my PhD proposal defense for my project, "Foundational studies for measuring the impact, prevalence, and patterns of publicly sharing biomedical research data." Dept of Biomedical Informatics, University of Pittsburgh.
In its third year, “PEGS China: Protein and Antibody Engineering & Development Summit” returns to Shanghai for 3 days of inspiring presentations and case studies featuring the latest trends and future potential of China’s biotech industry.
This year’s event comprises four content-driven conferences with over sixty global speakers, plus a new 1-day seminar on clinical & regulatory strategies for global and domestic IND and BLA filings. In addition, dedicated exhibit hall and poster viewing hours will provide invaluable opportunities for networking, deal-making and ideas exchange.
Ontology-Driven Clinical Intelligence: Removing Data Barriers for Cross-Disci...Remedy Informatics
The presentation describes how Remedy Informatics is advocating and innovating "flexible standardization" through an ontology-driven approach to clinical research. You will see in greater detail how a foundational, standardized Mosaic Ontology can be extended for more specific research applications and even more specific and focused disease research.
Dr. Dennis Wang discusses possible ways to enable ML methods to be more powerful for discovery and to reduce ambiguity within translational medicine, allowing data-informed decision-making to deliver the next generation of diagnostics and therapeutics to patients quicker, at lowered costs, and at scale.
The talk by Dr. Dennis Wang was followed by a panel discussion with Mr. Albert Wang, M. Eng., Head, IT Business Partner, Translational Research & Technologies, Bristol-Myers Squibb.
Presentation of a descriptive anaysis of the DCI from Thomson Reuters by Daniel Torres-Salinas, Evaristo Jiménez-Contreras and Nicolás Robinson-García at the STI Conference held in Leiden (The Netherlands) 3-5 september 2014 sti2014.cwts.nl
Tools and Technology for Advancing Rare Disease Research and Drug DevelopmentCovance
This white paper discusses virtual mapping of natural histories, the application of predictive modeling to better understand comorbidities and disease progressions as well as linkage to longitudinal real-world data sets. The goal is to improve diagnosis of patients, improve the design and conducting of trials, and enable development of more treatment options for people living with rare diseases.
Similar to McIntosh "Improving the quality of preprints with automated checks" (20)
This presentation was provided by William Mattingly of the Smithsonian Institution, during the closing segment of the NISO training series "AI & Prompt Design." Session Eight: Limitations and Potential Solutions, was held on May 23, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the seventh segment of the NISO training series "AI & Prompt Design." Session 7: Open Source Language Models, was held on May 16, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the sixth segment of the NISO training series "AI & Prompt Design." Session Six: Text Classification with LLMs, was held on May 9, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the fifth segment of the NISO training series "AI & Prompt Design." Session Five: Named Entity Recognition with LLMs, was held on May 2, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the fourth segment of the NISO training series "AI & Prompt Design." Session Four: Structured Data and Assistants, was held on April 25, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the third segment of the NISO training series "AI & Prompt Design." Session Three: Beginning Conversations, was held on April 18, 2024.
This presentation was provided by Kaveh Bazargan of River Valley Technologies, during the NISO webinar "Sustainability in Publishing." The event was held April 17, 2024.
This presentation was provided by Dana Compton of the American Society of Civil Engineers (ASCE), during the NISO webinar "Sustainability in Publishing." The event was held April 17, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, during the second segment of the NISO training series "AI & Prompt Design." Session Two: Large Language Models, was held on April 11, 2024.
This presentation was provided by Teresa Hazen of the University of Arizona, Geoff Morse of Northwestern University. and Ken Varnum of the University of Michigan, during the Spring ODI Conformance Statement Workshop for Libraries. This event was held on April 9, 2024
This presentation was provided by William Mattingly of the Smithsonian Institution, during the opening segment of the NISO training series "AI & Prompt Design." Session One: Introduction to Machine Learning, was held on April 4, 2024.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the eight and final session of NISO's 2023 Training Series on Text and Data Mining. Session eight, "Building Data Driven Applications" was held on Thursday, December 7, 2023.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the seventh session of NISO's 2023 Training Series on Text and Data Mining. Session seven, "Vector Databases and Semantic Searching" was held on Thursday, November 30, 2023.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the sixth session of NISO's 2023 Training Series on Text and Data Mining. Session six, "Text Mining Techniques" was held on Thursday, November 16, 2023.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the fifth session of NISO's 2023 Training Series on Text and Data Mining. Session five, "Text Processing for Library Data" was held on Thursday, November 9, 2023.
This presentation was provided by Todd Carpenter, Executive Director, during the NISO webinar on "Strategic Planning." The event was held virtually on November 8, 2023.
This presentation was provided by Rhonda Ross of CAS, a division of the American Chemical Society, and Jonathan Clark of the International DOI Foundation, during the NISO webinar on "Strategic Planning." The event was held virtually on November 8, 2023.
This presentation was provided by William Mattingly of the Smithsonian Institution, for the fourth session of NISO's 2023 Training Series on Text and Data Mining. Session four, "Data Mining Techniques" was held on Thursday, November 2, 2023.
This presentation was provided by Tiffany Straza of UNESCO, during the two-day "NISO Tech Summit: Reflections Upon The Year of Open Science." Day two was held on October 26, 2023.
More from National Information Standards Organization (NISO) (20)
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
4. What’s happening in preprints?
No standard way of reporting or
removing preprints
32 Retracted + 3 ‘Letters of
Concern’ from Covid preprints
Still exploring checks
Automating checks
7. Ripeta, LLC. All rights reserved. This is not to be shared without official permission.
ripetaReview
8. Ripeta, LLC. All rights reserved. This is not to be shared without official permission.
ripetaReview Quality
review of
one paper
ripetaReview
9. Ripeta, LLC. All rights reserved. This is not to be shared without official permission.
ripetaReview
Sample ripetaReview
Research Quality
Study Objective: Yes
Professionalism
ID: Confirmed with ORCID
Funding Statement: Yes
Reproducibility
DAS: Yes
Data Location: In paper
Code Availability: No
Data Location
Result: Text found
The data used to support the findings of this study are included
within the article.
Recommendations: Please consider depositing data and
materials into an accessible repository. Having data easily
accessible has shown to increase the number of citations to
your article. This also assists in making your work
reproducible.
Relationship between the ABO Blood Group and the COVID-19
Susceptibility
DOI: 10.1101/2020.03.11.20031096
Results
Feedback
12. Ripeta, LLC. All rights reserved. This is not to be shared without official permission.
ripetaReport
13. Ripeta, LLC. All rights reserved. This is not to be shared without official permission.
ripetaReport Report of
Portfolio of
Publications
Sample ripetaReport (Wellcome Trust)
18. Research
Relationship between the ABO Blood Group and the COVID-19 Susceptibility
DOI: 10.1101/2020.03.11.20031096
Here, we investigated the relationship between the ABO blood type
and the susceptibility to COVID-19 in patients from three hospitals in
Wuhan and Shenzhen, China to test if the former may be a biomarker
for the latter.
Study Objective
Scientific
Headings
Abstracts, Background/Introduction, Methods
20. Reproducibility
Relationship between the ABO Blood Group and the COVID-19 Susceptibility
DOI: 10.1101/2020.03.11.20031096
Data Availability
The data used to support the findings of this study are included within the article.
Data Availability
The data used to support the findings of this study are included within the article.
{Not Found}
Data Availability
Statement
Data Location
Code Availability
22. Covid Preprint
Analyses
ripetaScore Outcome Citations
Similarity nCoV spike protein
10.1101/2020.01.30.927871 Low Withdrawn 50
Hydroxychloroquine
10.1101/2020.03.16.20037135 Medium Questioned 3000
ABO Blood Group
10.1101/2020.03.11.20031096
Medium Overhyped 150
Potential vaccine targets
10.1101/2020.02.03.933226 High Published 450
23. Article DOI Study
Purpose
Author-
ship
Funding
Statement
Data
location
DAS Code
availability
10.1101/2020.01.30.927871 Yes 2 No None No No
Uncanny similarity of unique inserts in the 2019-nCoV spike
protein to HIV-1 gp120 and Gag
Methodology
Retrieval and alignment of nucleic acid and protein sequences
We retrieved all the available coronavirus sequences (n=55) from NCBI viral
genome database (https://www.ncbi.nlm.nih.gov/) and we used the GISAID (Elbe
& Buckland-Merrett, 2017)[https://www.gisaid.org/] to retrieve all available full-
length sequences (n=28) of 2019-nCoV as on 27 Jan 2020. Multiple sequence
alignment of all coronavirus genomes was performed by using MUSCLE
software (Edgar, 2004) based on neighbour joining method. Out of 55
coronavirus genome 32 representative genomes of all category were used for
phylogenetic tree development using MEGAX software (Kumar et al., 2018). The
closest relative was found to be SARS CoV.
24. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an
open-label non-randomized clinical trial
Article DOI Study
Purpose
Author-
ship
Funding
Statement
Data
location
DAS Code
availability
10.1016/j.ijantimicag.2020
.105949
Yes 1 Yes None No No
Elisabeth Bik took a close look at the IJAA article and
detailed a long list of serious problems with the study,
including questions about its ethical underpinnings, messy
confounding variables, missing patients, rushed and
conflicted peer review, and confusing data.
25. Relationship between the ABO Blood Group and the COVID-19 Susceptibility
Article DOI Study
Purpose
Author-
ship
Funding
Statement
Data
location
DAS Code
availability
10.1101/2020.03.11.200310
96
Yes 4 Yes In paper Yes No
26. Preliminary identification of potential vaccine targets for the COVID-19
coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies
Article DOI Study
Purpose
Author-
ship
Funding
Statement
Data
location
DAS Code
availability
10.1101/2020.02.03.933226 Yes 4 Yes External
repo
Yes Yes
30. Follow us for weekly
academic highlights,
transparency tips, and more!
@RipetaReview
@Ripeta
info@ripeta.com
www.ripeta.com
Stay
Informed
31. Leslie McIntosh
CEO
Cynthia Hudson
Vitale
COO, co-founder
Chris Westling
Data Engineer
Ruth Whittam
Data Scientist,
Lead
Josh Sumner
Data Scientist,
Intern
Leah Haynes
Data Scientist,
Intern
ripetinis
Paola Ortega
Saborío
Data Engineer
August
DeVore
Editor
33. ripetaData Research Professionalism Reproducibility
Open Access Ethical Approval Statement Data Availability Statements
Abstract Ethical Approval Organization Data Locations - Repository
Study Objective Author Contribution Statement Data Locations - PID
Funding Statement Competing Interests Data Locations - Identifiers
Funding Source Funding Source Data Locations - URL
Funding Grant ID Funding Grant ID Analysis Software
Count of Authors (single) Analysis Software Version
Self-Citations Statistical Methods
Author Identification Code Availability Statement